Vibrio vulnificus is an etiological agent causing serious systemic infections in the immunocompromised humans or cultured eels. This species commonly produces a hemolytic toxin consisting of the cytolysin domain and the lectin-like domain. For hemolysis, the 5 lectin-like domain specifically binds to cholesterol in the erythrocyte membrane, and to form a hollow oligomer, the toxin is subsequently assembled on the membrane. The cytolysin domain is essential for the process to form the oligomer. Three-dimensional structure model revealed that two domains connected linearly and the C-terminus was located near to the joint of the domains. Insertion of amino acid residues between two domains was found to cause 10 inactivation of the toxin. In the C-terminus, deletion, substitution or addition of an amino acid residue also elicited reduction of the activity. However, the cholesterol-binding ability was not affected by the mutations. These results suggest that mutation of the C-or N-terminus of the lectin-like domain may result in blockage of the toxin assembly. 
Introduction
Vibrio vulnificus is a facultative anaerobic gram-negative bacterium inhabiting ubiquitously at estuarine and marine environments (Janda et al., 1988; Chakraborty et al., 1997) . However, this bacterium is an etiological agent causing fatal septicemia in humans by 5 consumption of contaminated seafood, whereas most of the patients have underlying diseases such as hepatic cirrhosis, hepatitis or diabetes (Strom and Paranjpye, 2000; Miyoshi 2006) . V.
vulnificus also causes serious systemic infections called vibriosis in cultured eels (Tison et al., 1982) . This species commonly produces a hemolytic/cytolytic toxin termed V. vulnificus hemolysin (VVH) (Shinoda et al., 1985; Miyoshi et al., 1993) , which has been reported to 10 cause cytolysis of various eukaryotic cells, as well as erythrocytes (Yamanaka et al., 1990; Miyoshi et al., 1993; Kashimoto at al., 2010) . For hemolysis, the toxin binds specifically to cholesterol and is subsequently assembled on the membrane to form an oligomer (Yamanaka et al., 1987; Kim and Kim, 2002) . Although VVH is a single polypeptide consisting of 451 amino acid residues (Yamamoto et al., 1990) , it is divided into two functional domains, the 15 cytolysin domain (Gln 1 to Ala 318 ) essential for the toxin assembly and the lectin-like domain (His 319 to Leu 451 ) mediating the toxin binding (Olson and Gouaux, 2005) . Indeed, our recent study demonstrated that replacement of Thr 438 in the lectin-like domain caused significant change of the affinity to cholesterol (Senoh et al., 2008) . The VVH precursor is encoded in the vvhA gene (1416 bp), while it constitutes an operon with the vvhB gene (507 bp) (Yamamoto 20 et al., 1990) . Senoh et al. (2008) reported that the product of vvhB functioned as a chaperone to support the maturation of VVH.
The overall three-dimensional structures of bacterial hemolytic/cytolytic toxins are considerably similar each other even though their primary structures are not fairly related (Tilley and Saibil, 2006; Iacovache et al., 2010) . Vibrio cholerae, a human pathogen causing 25 4 cholera or enteric diseases, also produces a hemolytic toxin, of which amino acid sequence is 17 % identical with VVH (Yamamoto et al., 1990) . Based on the crystal structure of V.
cholerae hemolysin (Olson and Gouaux, 2005) , the tertiary structure model of VVH was constructed by using the SWISS-MODEL Workspace (Arnold et al., 2006) . The model revealed that two domains were connected linearly and the C-terminal leucine was located
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close to the joint of the domains (Miyoshi et al., unpublished) . This suggests that mutation of the N-or C-terminus of the lectin-like domain may result in inactivation of VVH because of change of the linear arrangement of the two domains. Kashimoto et al. (2010) recently found that mutation of Phe 314 located near to the joint of the domains caused remarkable reduction of the cytolytic activity. However, the mutated toxin was found to bind sufficiently to the 10 membrane. In the present study, several mutated toxins were prepared by using the cell-free translation system, and their hemolytic activities and cholesterol-binding abilities were compared.
Materials and methods

15
Bacterial strain and growth
V. vulnificus strain CDC B3547 isolated from human leg ulcer was used in the present study. The bacterium was cultivated overnight at 37 o C in Luria-Bertani broth (1 % trypton, 0.5 % yeast extract, 3.0 % NaCl, pH 7.5) with shaking. 
Toxin production by using the cell-free system
As described by Senoh et al. (2008) , the wild type or mutated toxin was produced with the rapid translation system (Roche Diagnostics, Mannheim, Germany) using the polymerase annealing at an appropriate temperature, 2-3 min extension at 68 o C.
In the second PCR, the sequences for T7 promoter and His 6 -Tag were added to the upstream, and the sequence for the T7 terminator was added to the down stream. The product of the first PCR was mixed with the RTS E. coli Linear Template Generation Set and His 6 -tag, and the admixture was subjected to the second PCR. After denaturation at 94 o C for 4 min, the Thereafter, the final cell-free translation was performed using the products of the second PCR as the linear template DNAs. The amplified DNA fragments corresponding to vvhA (1.0 µg) and vvhB (0.5 µg) were mixed with the RTS 100 Escherichia coli HY Kit, and the 15 translation was carried out at 25 o C for 6 hr according to the manufacture's manual.
For Western blotting, the crude toxin preparation was applied to a Phenyl-Sepharose HP 5/5 column, and the toxin was partially purified as described (Senoh et al., 2008) . The toxin thus prepared was treated at 100 o C for 5 min with an equal volume of the mixture of 2 % SDS and 5 % 2-mercaptoethanol (SDS-ME). An aliquot of the heat-treated sample was 20 subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on the PhastSystem using a PhastGel Gradient 10-15 (GE Healthcare, Buckinghamshire, England), and the proteins were transferred to a polyvinylidene difluoride membrane. Thereafter, the toxin was detected with the rabbit IgG antibody against VVH purified from strain CDC B3547 and the anti-rabbit IgG antibody conjugated with horseradish peroxidase (Cosmo-Bio, Tokyo,
Japan), and the density of the protein band detected was analyzed by using NIH Image version 2.1.
Hemolytic activity
The hemolytic activity was assayed according to the method of Shinoda et al. (1985) 5 with some modifications. The toxin preparation (50 µl) was diluted serially with 20 mM
Tris-HCl buffer (pH 7.5) containing 0.9 % NaCl and 0.01 % bovine serum albumin (TBS), and each of the toxin samples was allowed to act on 50 µl of 1 % sheep erythrocytes suspended into TBS at 37 o C. At 2 hr-incubation, the reaction was terminated by the addition of 0.4 ml of ice-cold TBS, and the supernatants were collected after centrifugation at 1000 x g 10 for 5 min. Thereafter, the amount of hemoglobin liberated from the disrupted erythrocytes was quantified by measuring absorbance at 540 nm, and the amount of the toxin causing 50 % hemolysis was determined, and then, the relative activity of each mutated toxin was estimated. 
Binding to cholesterol particles
The toxin preparation (10 µl) was allowed to act on cholesterol (1 to 10 µg in 1 µl of ethanol) in a total of 0.1 ml of TBS for 30 min at 0 or 37 o C. Thereafter, the cholesterol particles were collected by centrifugation (12000 x g for 5 min), rinsed twice with TBS and dissolved in an equal volume of SDS-ME by incubation at 37 o C for 30 min. An aliquot of the 20 sample thus prepared was subjected to SDS-PAGE on the PhastSystem using a PhastGel Gradient 10-15, and the toxin was detected by Western blotting. thus prepared was mixed with the toxin preparation (50 µl) and incubated at 37 o C for 2 hr.
Binding to erythrocyte membranes
Thereafter, the resealed ghosts were collected, and the toxin associated with the ghost was detected by SDS-PAGE followed by Western blotting. Senoh et al. (2008) documented the sufficient hemolytic activity of the wild type toxin
Results
3-1. Hemolytic activities of mutated toxins
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(sVVH) produced by using the cell-free translation system. In the present study, we prepared the cytolysin domain (Gln 1 to Ala 318 ) by using the same system and measured its hemolytic activity in the presence or absence of the lectin-like domain (His 319 to Leu 415 ). However, no hemolytic activity was observed even in the presence of the lectin-like domain, suggesting that the toxin must be produced as a single polypeptide to show the hemolytic activity. Next,
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we tested effect of the addition of amino acid residues to the N-terminus of the lectin-like domain. The hemolytic activity was reduced to 30 % by insertion of glycine-alanine between Ala 318 and His 319 and abolished completely by insertion of six glycine residues. Theses findings indicate that the direct connection of two domains is crucial to cause hemolysis.
The tertiary structure model reveled that the C-terminus of the lectin-like domain (Leu 451 )
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was located close to the joint of two domains. Therefore, it was considered that the mutation of the C-terminus might affect the hemolytic activity. As shown in Table 1 , the activity was reduced to less than 20 % by deletion of the C-terminal leucine (CΔ1). The preparation of the CΔ2 mutant was found to have no hemolytic activity; however, the Western blotting analysis indicated that this preparation contained the undetectable amount of the mutated toxin (data 25 8 not shown). Next, we tested effect of the addition of a residue to the C-terminus (Table 1) .
Although addition of leucine (VVH-L) or phenylalanine (VVH-F) gave a little impact in the hemolytic activity, addition of aspartic acid (VVH-D) or lysin (VVH-K) caused significant
reduction of the activity. In addition, we examined whether substitution of Leu 451 also causes inactivation of the toxin (Table 1 ). The toxin substituted to isoleucine (L451I) showed the 5 partial hemolytic activity; however, substitution to aspartic acid (L451D) or lysin (L451K) resulted in drastic decrease in the activity. In contrast, change of Lys 450 elicited less effect on the hemolytic activity ( Table 1 ).
The wild type and mutated toxins were partially purified by using a Phenyl-Sepharose HP 5/5 column (Senoh et al., 2008 ) and subjected to SDS-PAGE followed by Western blotting.
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The results demonstrated that any mutation did not affect the translation process because the comparative amounts of the mutated toxins could be detected (data not shown). Therefore, it is concluded that the C-terminus leucine in the lectin-like domain is important for the hemolytic activity. 
3-2. Binding of mutated toxins to cholesterol
In the first step of hemolysis, VVH binds to cholesterol in a temperature-independent manner (Shinoda et al., 1985) . Since the lectin-like domain alone can mediate this first step (Senoh et al., 2008) , it was speculated that the mutation of the C-terminus did not affect the ability to bind to cholesterol. The wild type or mutated toxin was allowed to act at 0 or 37 o C (Fig. 1A) . We also examined the binding of the mutated toxin, L451K, to erythrocyte membranes. The Western blotting analysis of the resealed erythrocyte ghosts incubated with sVVH or L451K demonstrated the comparative binding of the toxin to the membranes (Fig.   1B ). These findings indicate that the mutated toxins have the sufficient ability to bind to cholesterol. Therefore, the second process for hemolysis, assembly of the toxin molecules, 5 may be blocked in the mutated toxins. However, the follow-up experiments to determine dissociation constants or to compare the affinity of the toxins to cholesterol.
3-3. Hemolysis in the presence of the mutated toxin
The native PAGE is a useful method to detect the toxin oligomer formed by 10 auto-assembly on erythrocyte membrane or cholesterol particles (Miyoshi et al., 2004) .
However, when the cholesterol particles incubated with sVVH were subjected to native PAGE, no protein band corresponding to the toxin oligomer could be detected (data not shown). Next, we carried out modified SDS-PAGE of cholesterol particles incubated with sVVH, in which the heat-treatment of the sample with SDS-ME was omitted to protect dissociation of the 15 toxin oligomer to the monomer. However, the oligomer of sVVH could not be detected in the modified SDS-PAGE analysis (data not shown). Although it is not known why the toxin oligomer was not detected, the N-terminal His 6 -Tag in sVVH might disturb the mobility of the toxin oligomer in native PAGE or modified SDS-PAGE.
We also tested whether the presence of the excess amounts of the mutated toxin could 20 interfere the hemolysis elicited by the wild type toxin. The sVVH was mixed with CΔ1 or L451K at the molar ratio of 1:0 to 1:5, and the hemolytic activity of each mixture was compared. As shown in Fig. 2 , either mutated toxin showed no effect on the hemolytic activity.
This suggests that the mutated toxin could not interact with sVVH on the erythrocyte membrane. 
Discussion
VVH is a single polypeptide toxin consisting of two functional domains, the cytolysin domain (Gln 1 to Arg 318 ) and lectin-like domain (His 319 to Leu 451 ) (Olson and Gouaux, 2005) .
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This toxin is known to cause hemolysis through several steps . Namely, in the first step, the lectin-like domain binds specifically to cholesterol in a temperature-independent manner, and in the second step, the toxin forms a hollow oligomer through autoassembly in a temperature-dependent manner. Senoh et al. (2008) recently demonstrated that Thr 438 in the lectin-like domain was related to the binding to cholesterol.
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On the other hand, Kashimoto et al. (2010) reported that mutation of Phe 314 , which is in the cytolysin domain but is located near to the joint of two domains, elicited elimination of the ability to form the toxin oligomer. The present study showed that mutation of Leu 451 , of which location is also close to the joint of the domains, caused inactivation of VVH without significant reduction of the ability to bind to cholesterol particles and sheep erythrocyte 15 membranes. In addition, VVH had lost the hemolytic activity by insertion of residues to the N-terminus of the lectin-like domain. Although significant change in the tertiary structure model was not observed, these mutations might result in blockage of formation of the toxin oligomer through autoassembly.
V. vulnificus is a ubiquitous microorganism in the estuarine and marine environments 20 (Janda et al., 1988; Chakraborty et al., 1997) whereas an etiological agent causing fatal septicemia in humans by eating contaminated seafood (Strom and Paranjpye, 2000; Miyoshi 2006) . VVH is commonly produced by V. vulnificus as a major exocellular toxin (Shinoda et al., 1985; Miyoshi et al., 1993) , and its structure gene has been used as a characteristic gene to identify the bacterium (Hill et al., 1991; Senoh et al., 2005 non-toxic and safety antigens/toxoids to produce the specific antibody to the toxin. 
